[Exercise addiction]. / Addiction à l'exercice.

Exercise addiction, although not yet officially recognized, can be defined as the harmful practice of physical exercise, described as a compulsive need, where damage take precedence over the benefits of this practice, with a continuation of this behavior despite the negative consequences. A number of risk factors have been identified, including psychopathological conditions such as eating disorders or other addictions. It is possible to detect this addiction and assess its intensity using multidimensional questionnaires, even the clinical relevance and thresholds of which are still debated. Despite the absence of validated treatments, motivational approaches and cognitive-behavioural therapies can be useful, combined with nutritional management if necessary, as well as management of concomitant disorders.

L'addiction à l'exercice peut être définie par une pratique compulsive de l'exercice physique, où les dommages prennent le pas sur les bienfaits, avec une poursuite du comportement malgré les conséquences négatives. Certains facteurs de risque individuels, environnementaux, et propres au sport ont été identifiés tels que la recherche d'une amélioration des performances, des troubles du comportement alimentaire, ou d'autres addictions. Il est possible de détecter cette addiction et d'en évaluer l'intensité grâce à des questionnaires dont la pertinence clinique et les seuils sont encore discutés. Malgré l'absence de traitements validés, l'approche motivationnelle et les thérapies cognitives et comportementales peuvent être utiles, associées à une prise en charge nutritionnelle si nécessaire, ainsi que le traitement des troubles concomitants.

The load borne by the Achilles tendon during exercise: A systematic review of normative values.

The Achilles tendon (AT) can be exposed to considerable stress during athletic activities and is often subject to pathologies such as tendinopathies. When designing a prevention or rehabilitation protocol, mechanical loading is a key factor to consider. This implies being able to accurately determine the load applied to the AT when performing exercises that stress this tendon. A systematic review was performed to synthesize the load borne by the AT during exercises/activities. Three databases (Pubmed, Embase and Cochrane) were searched for articles up to May 2021, and only the studies assessing the AT load in newtons relative to body-weight (BW) on humans during activities or exercises were included. Most of the 11 included studies assessed AT load when running or walking (N = 10), and only three tested exercises were usually performed during rehabilitation. The load on the tendon ranged from 2.7 to 3.95 BW when walking, from 4.15 to 7.71 BW when running, and from 0.41 to 7.3 BW according to the strengthening exercise performed. From the collected data, a progression of exercises progressively loading the Achilles tendon, as well as the possible connections with walking and running activities, could be defined. However, the trends highlighted in the relationship between tendon loading and walking or running speeds present some inconsistencies. Further research is still needed to clarify them, but also to complete the data set in healthy and injured people.

Botulinum Toxin A for Chronic Exertional Compartment Syndrome: A Retrospective Study of 16 Upper- and Lower-Limb Cases.

OBJECTIVE: To assess initial and mid-term efficacy of botulinum toxin A (BoNT-A) injections in patients with chronic exertional compartment syndrome (CECS) in the lower and upper limbs. DESIGN: Retrospective monocentric study. SETTING: A University Hospital Department of Physical Medicine and Rehabilitation. PATIENTS: Sixteen patients with CECS of the lower and upper limbs treated with BoNT-A injections (first-line treatment) were included. INTERVENTIONS, MAIN OUTCOME MEASURES: We collected data from a follow-up consultation (initial pain reduction [complete, partial, or ineffective] and specific activities triggering CECS) and a subsequent phone questionnaire (mid-term efficacy, pain recurrence, and adverse effects). RESULTS: Sixteen patients were included (median age: 25.5 years), and 68.75% reported initial efficacy (4 partial and 7 complete); 8/16 patients were able to resume the activity that triggered CECS. All the patients with initial partial efficacy had pain recurrence (median time of 2.25 months). Among patients with initial complete efficacy, 57.14% had recurrence (median time of 5 months). Minor adverse effects were observed, but with no functional impact. CONCLUSION: In 16 individuals with CECS treated with BoNT-A injections, we observed moderate efficacy without major adverse effects, but an initial improvement was often followed by recurrence, especially among those with partial initial efficacy.

SmartSwim, a Novel IMU-Based Coaching Assistance.

Swimming coaches provide regular timed and technical feedback to swimmers and guide them efficiently in training sessions. Due to the complexity of swimmers' performance, which is not visible in qualitative observation, quantitative and objective performance evaluation can better assist the coach in this regard. Inertial measurement units (IMUs) are used in swimming for objective performance evaluation. In this study, we propose a new performance evaluation feedback (SmartSwim) using IMU and investigate its effects on the swimmer's weekly progress. Measurements were conducted each week with 15 competitive swimmers for 10 weeks using a Sacrum IMU. The SmartSwim report included a comprehensive representation of performance based on goal metrics of each phase extracted from the IMU signals. The swimmers were divided into two groups: the experimental and control groups. The SmartSwim report for each swimmer in the experimental group was given to the coach, who used it to adjust the training accordingly. The results showed that the experimental group outperformed the control group when comparing each swimmer, each session and the whole sessions. At the level of each individual, more members of the experimental group showed significant downward trend of average lap time (Mann-Kendall trend test, 95% confidence level). While comparing the sessions, the experimental group showed significantly lower lap time than the control group from the sixth session onwards (p-value < 0.05 from t-test). Considering all sessions, the experimental group showed significantly higher progress, lower average lap time, and more consistent records (Mann-Whitney U test at 95% confidence level) than the control group. This study demonstrated that SmartSwim can assist coaching by quantitatively assessing swimmers' performance, leading to more efficient training.

[Exercise training with blood flow restriction : mechanisms and applications]. / Entraînement avec occlusion vasculaire: mécanismes et applications.

Traditional guidelines state that substantial muscle development requires training at least 70% of the one-repetition maximum (1RM) load. However, recent evidence has proven that low load training (20-40 % 1RM) combined with moderate blood flow restriction (BFR) can also lead to improvements in muscle mass and strength. While BFR has primarily been studied in clinical populations, emerging evidence demonstrates the effectiveness of BFR in sport. This article displays the mechanisms, methods, protocols, risks, and known effects of BFR.

Les directives traditionnelles stipulent qu'un développement musculaire nécessite un entraînement avec une charge minimale correspondant à 70 % du maximum d'une répétition (1RM). Cependant, des preuves récentes suggèrent que l'entraînement à faible charge (20-40 % de 1RM), combiné à une restriction modérée du flux sanguin (Blood Flow Restriction, BFR), peut également entraîner des améliorations de la masse et de la force musculaires. Alors que le BFR a d'abord été principalement étudié sur des populations cliniques, de nouveaux travaux rapportent son efficacité en milieu sportif. Cet article présente les mécanismes, les méthodes, les protocoles, les risques ainsi que les effets connus du BFR.

[Prevention and management of running-related injuries]. / Prévention et prise en charge de la blessure liée à la course à pied.

Running related injury is a complex, multifactorial phenomenon that remains difficult to explain. However, there are available tools for clinicians allowing prevention (primary or tertiary) and rehabilitation optimization, thus reducing the consequences of the injury and time before returning to participation. These tools rely mainly on training load monitoring and clinical evaluation of stride biomechanical analysis. Unfortunately, they currently remain poorly known by practitioners, while allowing the opportunity to address the challenge of managing the injured runner, including a faster return to run, but also the prevention of a potential recurrence. It requires targeted intervention and education of the patient on the factors leading to the injury.

La blessure liée à la course à pied est un phénomène complexe, multifactoriel dont l'explication reste difficile. Cependant, des outils à disposition des cliniciens permettent d'agir de manière préventive (primaire ou tertiaire) et d'optimiser la rééducation afin de réduire les conséquences de la blessure et le délai avant la reprise de l'activité. Ces outils portent principalement sur le suivi de la charge d'entraînement et l'utilisation clinique de l'analyse biomécanique de la foulée. Ils sont toutefois aujourd'hui mal connus par les praticiens alors que leur utilisation permet de répondre à l'enjeu de la prise en charge du coureur comprenant un retour le plus rapide possible à la pratique, mais également la prévention d'une potentielle récidive. Cela sous-tend un travail ciblé et une éducation du patient sur les facteurs entraînant la blessure.

Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: a consensus statement from French-speaking experts.

PURPOSE: There has been much debate regarding the use of intra-articular injections of platelet-rich plasma (PRP) as symptomatic treatment for knee osteoarthritis. The objective of this consensus was to develop guidelines for PRP injections in knee osteoarthritis according to the French National Authority for Health recommendations. METHODS: Fifteen physicians from different French-speaking countries (10 rheumatologists, 4 specialists in rehabilitation and sports medicine and 1 radiologist) were selected for their expertise in the areas of PRP and osteoarthritis. A comprehensive literature review was conducted on Medline including all published therapeutic trials, open studies, meta-analysis and systematic reviews focusing on the effects of PRP in knee OA, as well as fundamental studies concerning the characteristics of the various types of PRP and their mechanisms, indexed before April 2019. Using the method recommended by the French National Authority for Health inspired by the Delphi consensus process, 25 recommendations were finally retained and evaluated. The recommendations were classified as appropriate or not appropriate, with strong or relative agreement, or uncertain if a consensus was not achieved. RESULTS: Among the 25 recommendations selected, the main ones are the following: (1) Intra-articular injections of PRP are an effective symptomatic treatment for early to moderate knee osteoarthritis. This recommendation was considered appropriate with a relative agreement (Median = 8; rank = 6-9). Level of evidence 1A. (2) A PRP treatment sequence in knee osteoarthritis may include 1-3 injections. This recommendation was considered appropriate with a strong agreement (Median = 9; rank = 7-9). Level of evidence 1A. (3) Leucocytes-poor PRP should be preferred in knee osteoarthritis. This recommendation was considered appropriate with a relative agreement (Median = 8; rank = 5-9). Level of evidence 5. (4) Intra-articular PRP knee injections should be performed under ultrasound or fluoroscopic guidance. This recommendation was considered uncertain with no consensus (Median = 8; rank = 3-9). Level of evidence 5. (5) PRP should not be mixed with an anesthetic or intra-articular corticosteroid. This recommendation was considered appropriate with a relative agreement (Median = 9; rank = 6-9). Level of evidence 5 CONCLUSION: Those 25 recommendations should standardize and facilitate the use of IA PRP injections, which are considered by experts as an effective treatment especially in early or moderate knee OA. Although a strong or relative agreement from the experts was obtained for most of the recommendations, many of them had a very low level of evidence (Level 5) and were principally based on the clinical experience of the experts.

[Plantar fasciitis: update 2021]. / Aponévropathie plantaire : mise au point 2021.

Plantar heel pain affects 4 to 9% of the population and is a common reason for consultation. Plantar fasciitis is the most frequent cause. Its diagnosis is essentially clinical, possibly supported initially by combination of X-ray/ultrasound. Ultrasound is the modality of choice to confirm the diagnosis. The prognosis is favorable, but the evolution can be long. Its management should be structured in a progressive manner, based on therapeutic education and physical measures. These simple measures have the highest level of evidence of effectiveness and should be implemented before proposing, sometimes too early, second-line therapies.

Les talalgies plantaires touchent 4 à 9 % de la population et sont un motif fréquent de consultation en médecine générale et en médecine du sport. L'aponévropathie plantaire en est la cause la plus fréquente. Son diagnostic est essentiellement clinique, éventuellement complété en première intention par le couple radiographie/échographie. Cette dernière est l'examen de choix permettant de confirmer le diagnostic. De pronostic favorable, sa durée d'évolution peut être longue. Sa prise en charge doit être structurée de façon progressive en s'appuyant sur l'éducation thérapeutique et des mesures physiques. Ces mesures simples montrent le niveau de preuve d'efficacité le plus élevé et doivent impérativement être mises en place avant de proposer, parfois trop précocement, des thérapeutiques de seconde intention.

[Sweat as an indicator of health]. / La sueur comme indicateur de la santé.

Sweat is a body fluid produced by the sweat glands and is mainly composed of water. Sweat has various functions, the two main ones being the evacuation of heat produced by the body, especially during exercise, and the maintenance of skin homeostasis. Its production is highly variable and depends on many individual and environmental factors. Various diseases or conditions affect its proper functioning. This article presents an overview of the characteristics, the main health issues, and the current and potential applications related to sweat.

La sueur est un fluide corporel produit par les glandes sudoripares et composé principalement d'eau. La transpiration remplit diverses fonctions, dont les principales sont l'évacuation de la chaleur produite par l'organisme, en particulier durant l'effort physique, et le maintien de l'homéostasie de la peau. Sa production est très variable quantitativement et qualitativement et dépend de multiples facteurs individuels et environnementaux. Différentes pathologies ou conditions altèrent son bon fonctionnement. Cet article présente un aperçu des caractéristiques, des principaux problèmes de santé et des applications actuelles et potentielles en lien avec la sueur.

Injury frequency and characteristics (location, type, cause and severity) differed significantly among athletics ('track and field') disciplines during 14 international championships (2007-2018): implications for medical service planning.

OBJECTIVE: To analyse differences between athletic disciplines in the frequency and characteristics of injuries during international athletics championships. METHODS: Study design, injury definition and data collection procedures were similar during the 14 international championships (2007-2018). National medical teams and local organising committee physicians reported all newly incurred injuries daily on a standardised injury report form. Results were presented as number of injuries and number of injuries per 1000 registered athletes, separately for male and female athletes, and for each discipline. RESULTS: From a total of 8925 male and 7614 female registered athletes, 928 injuries were reported in male and 597 in female athletes. The discipline accounting for the highest proportion of injuries was sprints, for both men (24%) and women (26%). The number of injuries per 1000 registered athletes varied between disciplines for men and women: highest in combined events for male athletes (235 (95% CI 189 to 281)) and female athletes (212 (95% CI 166 to 257)), and lowest for male throwers (47 (95% CI 35 to 59)) and female throwers (32 (95% CI 21 to 43)) and for female race walkers (42 (95% CI 19 to 66)). Injury characteristics varied significantly between disciplines for location, type, cause and severity in male and female athletes. Thigh muscle injuries were the main diagnoses in the disciplines sprints, hurdles, jumps, combined events and race walking, lower leg muscle injuries in marathon running, lower leg skin injury in middle and long distance running, and trunk muscle and lower leg muscle injuries in throws. CONCLUSIONS: Injury characteristics differed substantially between disciplines during international athletics championships. Strategies for medical service provision (eg, staff, facilities) during athletics championships should be discipline specific and be prepared for targeting the main injuries in each discipline.

[Optimizing nutritional supplementation in sports]. / Optimiser la supplémentation nutritionnelle chez les sportifs.

The enthusiasm for nutritional supplements among athletes of any level seems inversely correlated to the real impact of these products; or at least this might be concluded after reading most systematic reviews and guidelines. Despite being frequently consumed, the supplements that have shown a positive effect on health or performance are rare. However, specific situations can require a supplementation, and this article outlines how to identify these situations and how to pick the right supplement for each condition. We also discuss the reason why providing evidence for an effect on health or performance is particularly challenging in this field.

L'enthousiasme des sportifs à l'égard des compléments alimentaires est-il inversement proportionnel à l'impact de ces substances ? C'est ce que l'on pourrait conclure à la lecture des essais randomisés et des guidelines. Malgré une prévalence de consommation élevée, rares sont les suppléments pour lesquels il existe un effet avéré. Dans certaines situations, une supplémentation peut être toutefois utile, voire nécessaire. Comment les identifier ? Quels suppléments ont un effet ergogène, et dans quelles conditions ? Cet article répond à ces questions et explicite également pourquoi il est particulièrement difficile de faire la preuve de l'efficacité de ces produits.

[Cryotherapy chambers and cold-water immersion : therapeutic use and risks]. / Chambres de cryothérapie et immersion en eau froide†: utilisation thérapeutique et risques.

Whole body cryotherapy is mainly performed either by immersion in cold water or in a cryotherapy chamber. Practiced since Antiquity and considered as a «â€…natural ¼ method, cryotherapy is attracting more and more followers. Beneficial health effects have been described in the literature. However, interpretation of its effects is difficult due to low quality of current studies. Cryotherapy could however be useful in addition to conventional therapies in various pathologies and situations, provided that the risks, contraindications and rules of good practice are known.

La cryothérapie du corps entier se pratique principalement soit par immersion en eau froide, soit en chambre de cryothérapie. Pratiquée depuis l'Antiquité et considérée comme une méthode «â€…naturelle ¼, la cryothérapie tend à attirer de plus en plus d'adeptes. Des effets bénéfiques pour la santé ont été décrits dans la littérature. Néanmoins, l'interprétation de ses effets est difficile en raison de la faible qualité des études actuelles. La cryothérapie pourrait toutefois être utile en complément des thérapies classiques dans diverses pathologies et situations, à condition de connaître les risques, les contre-indications et les règles de bonnes pratiques.

[Heart rate variability: methods, limitations and clinical examples]. / Analyse de la variabilité de la fréquence cardiaque†: méthodes, limites et exemples cliniques.

Heart rate variability (HRV) is an analysis of milliseconds variations in intervals between heartbeats and has become an increasingly used tool for clinical investigation of fatigue, especially in athletes. Eliciting an indirect index of the autonomic nervous system regulation on the heart rate, HRV correlates with different fatigue states and appears to be a powerful biomarker in their monitoring. This article presents the tools to familiarize with this method while detailing good practices for use and interpretation. A method allowing characterization of different fatigue states is also presented for a clinical use with a systemic approach.

L'analyse de la variabilité de la fréquence cardiaque (VFC) s'intéresse à l'observation des variations en millisecondes des intervalles entre les battements cardiaques et devient un outil d'investigation clinique de la fatigue de plus en plus utilisé, notamment chez les athlètes. Les paramètres étudiés reflètent indirectement la régulation de la fréquence cardiaque par le système nerveux autonome et la VFC est corrélée à différents états de fatigue, se révélant être un puissant biomarqueur dans le suivi de ces derniers. Cet article vise à donner les bases permettant de cerner la thématique et précise les bonnes pratiques quant à son utilisation et son interprétation. Une méthode permettant de caractériser différents états de fatigue est également présentée et donne des pistes pour une utilisation en clinique avec une approche systémique.

Development and Validation of a Questionnaire to Assess Barriers to Physical Activity After Stroke: The Barriers to Physical Activity After Stroke Scale.

OBJECTIVE: To develop and validate a self-reported questionnaire assessing the barriers to physical activity (PA) among stroke survivors. DESIGN: Psychometric study. SETTING: Ambulatory stroke care. PARTICIPANTS: A total of one hundred and forty-six (N=146) individuals were included in this study. In stage 1, community-living stroke survivors (n=37; 13 women) with low-moderate disability (modified Rankin Score 0-3, stroke >3mo) were included. In stage 2, participants (n=109; 40 women) with same characteristics were included. Nine professionals experienced in PA for poststroke patients formed an expert panel. INTERVENTIONS: In stage 1, semistructured interviews identified perceived barriers to PA, which were then selected by the expert panel and grouped on a Barriers to Physical Activity After Stroke (BAPAS) scale. In stage 2, stroke participants completed a personal information questionnaire and the BAPAS scale. MAIN OUTCOME MEASURES: An item selection process with factor analysis was carried out. The suitability of the data set was analyzed using the Kaiser-Meyer-Olkin coefficient, internal consistency was evaluated by Cronbach α, and concurrent validity was assessed with Spearman correlation coefficients between the BAPAS scale and the modified Rankin Scale. Test-retest repeatability was estimated using 2-way random effects intraclass correlation coefficient model 2,1 at 4-6 day follow-up (n=21). RESULTS: Factor analysis supported a 14-item BAPAS that explained 62% of total variance (Kaiser-Meyer-Olkin=0.82) and total score calculated higher than 70 (higher scores for higher barriers). Cronbach α was 0.86, Spearman correlation with the modified Rankin Scale was r=0.65 (P<.001), and test-retest intraclass correlation coefficient was 0.91 (95% CI, 0.79-0.97). The BAPAS scores were higher in patients with greater disabilities and in those with a longer time since the stroke event (P<.01). CONCLUSION: We developed and validated the BAPAS scale to assess barriers to PA in stroke survivors with low-moderate disability with promising psychometric properties.

[Hamstring injury prevention]. / Prévention des lésions musculaires des ischio-jambiers.

Hamstring muscle injury is the first diagnosis of injury in sports involving sprints. Its prevention represents a fundamental challenge for the technical and health professionals around the athletes. Risk factors have been described and can be used for screening at-risk individuals (age, history of hamstring injury, strength deficit). Although every determinant of the occurrence of these injuries has not yet been determined, and currently available preventive measures are not fully effective (eccentric muscle strengthening and strength deficit screening), these preventive measures do exist and must be implemented to the benefit of athletes before more comprehensive approaches are developed and demonstrate greater efficiency.

La lésion musculaire des ischio-jambiers est le premier diagnostic de blessure dans les sports impliquant le sprint. Sa prévention représente un enjeu fondamental pour les professionnels techniques et de santé autour des sportifs. Des facteurs de risque ont été décrits et peuvent être utilisés dans le cadre d'un dépistage de sujet à risque (âge, antécédent(s) de lésion des ischio­jambiers, déficit de force). Bien que tous les déterminants de la survenue de ces blessures n'aient pas encore été appréhendés et que les mesures de prévention actuellement disponibles (renforcement musculaire excentrique et dépistage du déficit de force) ne soient pas d'une efficacité totale, ces dernières existent et doivent être mises au profit des sportifs avant que des approches plus globales ne soient développées et fassent preuve d'une meilleure efficacité.

[The acute management of muscle injuries in 2018]. / Prise en charge des lésions musculaires aiguës en 2018.

Acute muscle lesions are frequent conditions in sports traumato-logy. Intrinsic traumatic mechanism (excessive stretch) is more prevalent that extrinsic mechanism (direct shock or lacerations). The diagnosis is generally based on the injury mechanism description together with the clinical examination. The ultrasonography is helpful in order to evaluate the severity of the lesion and the time to sports resumption. The initial management is based on the POLICE acronym: Protection, Optimal loading, Ice, Compression, and Elevation. For high grade muscle lesions, patients might benefit from either ultrasound-guided hematoma evacuation or surgical repair. Non-steroid anti-inflammatory drugs should be avoided within the first days. The rehabilitation should begin 48h after the trauma, whatever the severity of the lesion.

Les lésions musculaires sont fréquentes en traumatologie sportive. Le mécanisme traumatique est plus fréquemment intrinsèque (par élongation) qu'extrinsèque (par choc direct ou lacération). Le diagnostic se fait sur la base de la description du mécanisme lésionnel et de l'examen clinique. L'estimation de la gravité et des délais de reprise est aidée par les examens d'imagerie, comme l'échographie. La prise en charge immédiate se base sur le protocole POLICE (Protection, Optimal loading, Ice, Compression, Elevation). Les anti-inflammatoires non stéroïdiens sont à proscrire. Les lésions de haut grade peuvent bénéficier d'une ponction-évacuation d'hématome, voire d'une réparation chirurgicale. Il est recommandé de débuter une rééducation adaptée dès 48 heures après le traumatisme, quelle que soit la sévérité de la lésion initiale.

Multiple Sclerosis and Clinical Gait Analysis before and after Fampridine: A Systematic Review.

BACKGROUND: Gait impairment is one of the most disabling symptoms in people with multiple sclerosis (PwMS). Fampridine, has demonstrated a positive effect on gait speed in PwMS after 14 days of treatment but the long-term effects have not yet been demonstrated. This study reviews the long-term effects of fampridine on gait in PwMS. SUMMARY: This systematic review was conducted according to the PRISMA statement. Studies were considered long term if treatment exceeded 28 days. From the 498 studies identified, 18 (2,200 patients) fulfilled all eligibility criteria. Only 3 studies followed-up patients for >1 year and one of these showed a non-significant improvement in the gait speed. Key Messages: Fampridine seems to be beneficial at improving gait speed in PwMS in the long term. Further long-term studies are needed on related gait and functional parameters.